Journal profile · Precision Medication
Precision Medication
ISSN 2950-5232 · KeAi · China · Quarterly · Founded 2024
FollowGet an email when its zone, impact factor or warning status changes
Precision Medication: fully open access; APC about USD 1,000; community-reported acceptance: 60%; 21 articles in 2025.
Scope
Aims, scope and focus
Precision Medication is published by KeAi. By OpenAlex counts of its recent articles, its largest topics are Antibiotics Pharmacokinetics and Efficacy, Pharmacogenetics and Drug Metabolism and Pharmaceutical Practices and Patient Outcomes, together about 24.4% of its articles. Its main subfields are Pharmacology. (generated from OpenAlex topic counts and CAS ranking data)
Precision Medication is an open-access, peer-reviewed journal that focuses on and rapidly reports high-level research findings related to precision medication. It aims to promote the application of research output in solving clinical problems and improving patient outcomes, and provides an open and shared platform for pharmacists, physicians, researchers and pharmaceutical R&D personnel. This will foster the construction of a precision medication disciplinary system and its integration with multiple disciplines. The scope of the journal covers Development of policies and guidelines related to precision medication Novel research methodologies for precision medication Construction and efficacy evaluation of precision medication system Digital health and precision medication Information technology strategy and precision medication Pharmacoeconomics and precision medication Methodological research associated with precision medication Pharmacogenomics research and clinical medication Pharmaco-metabonomics research and clinical medication Pharmaco-intestinal lora research and clinical medication Tumor targeted drugs New drug development and transformation Precision medication for chronic diseases Precision medication of traditional Chinese medicine
From the journal's Aims & Scope
Research area (LetPub): Precision Medication
Editor-in-chief Haibin DaiPublisher website
Editorial board by country: 6 in mainland China (about 38%); most named Mainland China 6, United States 4, Germany 1, Italy 1, Canada 1 (16 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Antibiotics Pharmacokinetics and EfficacyMedicine9.8%
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics7.3%
- Pharmaceutical Practices and Patient OutcomesMedicine7.3%
- Computational Drug Discovery MethodsComputer Science6.1%
- Pneumonia and Respiratory InfectionsMedicine6.1%
- Diabetes Treatment and ManagementMedicine4.9%
- Traditional Chinese Medicine AnalysisMedicine4.9%
- Pharmacy and Medical PracticesPharmacology, Toxicology and Pharmaceutics4.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
DOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
- h-index
- 4OpenAlex ·
- i10-index
- 0OpenAlex ·
- 2-year mean citedness
- 0.98OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 59 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 25 | 25 | 45 |
| 2025 | 21 | 21 | 13 |
| 2024 | 13 | 13 | 0 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average acceptance (community reports)
- 60%LetPub ·
- Submission to publication (journal-reported)
- about 14 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,000 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 0 | — | — | |
| Publisher website | USD 1,000 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 300 words
- Keywords
- ≥ 5
- Manuscript length
- ≤ 5,000 words
- Reference style
- Vancouver
Article types accepted8
- case reportPrecision Medication will accept the following types of articles: Research Article, Review Article, Systematic Review, Commentary, Case Report, Editorial, Discu…Length not stated
- commentaryPrecision Medication will accept the following types of articles: Research Article, Review Article, Systematic Review, Commentary, Case Report, Editorial, Discu…Length not stated
- discussionPrecision Medication will accept the following types of articles: Research Article, Review Article, Systematic Review, Commentary, Case Report, Editorial, Discu…Length not stated
- editorialPrecision Medication will accept the following types of articles: Research Article, Review Article, Systematic Review, Commentary, Case Report, Editorial, Discu…Length not stated
- research articlePrecision Medication will accept the following types of articles: Research Article, Review Article, Systematic Review, Commentary, Case Report, Editorial, Discu…Length not stated
- review articlePrecision Medication will accept the following types of articles: Research Article, Review Article, Systematic Review, Commentary, Case Report, Editorial, Discu…Length not stated
- short communicationPrecision Medication will accept the following types of articles: Research Article, Review Article, Systematic Review, Commentary, Case Report, Editorial, Discu…Length not stated
- systematic reviewPrecision Medication will accept the following types of articles: Research Article, Review Article, Systematic Review, Commentary, Case Report, Editorial, Discu…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI in scientific writing
Authors are encouraged to declare the use of generative AI in scientific writing upon submission of the paper. The following guidance refers only to the writing process, and not to the use of AI tools to analyse and draw insights from data as part of the research process: Generative AI and AI-assisted technologies should only be used in the writing process to improve the readability and language o…
Source ↗Publisher website ·- Authorship Authorship Statement
For transparency, we encourage authors to submit an author statement file outlining their individual contributions to the paper using the relevant CRediT roles: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Visualization; Roles/Writing - original draft; Writing - review & edi…
Source ↗Publisher website ·- License & copyright Copyright
This journal is a peer-reviewed, fully open access journal owned by Chinese General Practice Publishing House Co., Ltd, who retains copyright of the overall compiled journal and the compiled issues. For the single article, Authors will transfer copyright to Chinese General Practice Publishing House Co., Ltd, and KeAi Communications Co., Ltd. and Chinese General Practice Publishing House Co., Ltd w…
Source ↗Publisher website ·- Open access Open Access
Indexed in DOAJ Model summary
Every peer-reviewed research article appearing in this journal will be published open access. This means that the article is universally and freely accessible via the internet in perpetuity, in an easily readable format immediately after publication. The open access publication fee for this journal is USD 1000, plus taxes. Before December 31st 2026, the open access publication fee is paid by Chine…
Source ↗Publisher website ·- Peer review Peer review
Open access, peer-reviewed journal Model summary
This journal operates a double blind review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's dec…
Source ↗Publisher website ·- Preprints Preprints
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Before you submit
Four checks before submitting to Precision Medication
- 1ScopeRecent output centres on Antibiotics Pharmacokinetics and Efficacy, Pharmacogenetics and Drug Metabolism.Check scope
- 2Article type and formatAbstract: ≤ 300 words; Keywords: ≥ 5; Manuscript length: ≤ 5,000 words.Author guidelines ↗
- 3English languagePolish grammar and academic style before you submit: it lowers the risk of rejection for language and improves your chances of acceptance.
- 4FeesUSD 1,000 (DOAJ), waivers availableFee details
The checks are built from this page's data.
Profile
Publication details and official links
- Publisher
- KeAi
- Country or region
- China
- Language
- English
- Frequency
- Quarterly
- Founded
- 2024
- ISSN
- 2950-5232
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Precision Medication
What are the manuscript requirements of Precision Medication?
According to the journal's author guidelines: Abstract: ≤ 300 words; Keywords: ≥ 5; Manuscript length: ≤ 5,000 words; Reference style: Vancouver. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Precision Medication based?
Of the 16 board members whose country the journal's board page names, 6 (about 38%) are in mainland China; the countries named most often are Mainland China (6), United States (4) and Germany (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Precision Medication?
According to LetPub and DOAJ records, Precision Medication is indexed in DOAJ.
Is Precision Medication open access, and what is the APC?
Precision Medication is a fully open-access journal. APC about USD 1,000.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .